November 16, 2015 | The Israel Biotech Fund, a new fund founded by Dr. Yuval Cabilly will receive investment of $50-100 million from Nasdaq-traded biomedical company Biogen, and Cabilly’s father, Dr. Shmuel Cabilly, a renowned oncologist and research scientist. According to Globes, the fund is intended to focus on Israeli biotech companies, an area of investment in which the Cabillys already have considerable experience.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023

Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023

Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023

Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments